Quarterly report pursuant to Section 13 or 15(d)

CONCENTRATIONS

v3.24.3
CONCENTRATIONS
9 Months Ended
Sep. 30, 2024
CONCENTRATIONS  
CONCENTRATIONS

NOTE 16 - CONCENTRATIONS

 

Financial instruments and related items, which potentially subject the Company to concentrations of credit risk, consist primarily of cash and trade receivables. The Company places its cash and temporary cash investments with high credit quality institutions. At times, such investments may be in excess of the FDIC insurance limit.

 

The Company’s revenues earned from sale of products and services for the three months ended September 30, 2023 included 87% from one customer of the Company’s total revenues.

 

The Company’s revenues earned from sale of products and services for the nine months ended September 30, 2024 included 89% from six customers of the Company’s total revenues.

 

The Company’s revenues earned from sale of products and services for the nine months ended September 30, 2023 included 74% from two customers of the Company’s total revenues.

 

At September 30, 2024, the Company has no accounts receivable. At December 31, 2023, one customer accounted for 100% of the Company’s total accounts receivable with an amount of $740.